-+ 0.00%
-+ 0.00%
-+ 0.00%

CLINUVEL expands Singapore RD&I Centre to pioneer next-generation peptide therapies

Barchart·12/07/2025 20:37:00
Listen to the news

EXECUTIVE SUMMARY

MELBOURNE, Australia and SINGAPORE, Dec. 07, 2025 (GLOBE NEWSWIRE) -- CLINUVEL PHARMACEUTICALS LTD today announced a significant expansion of its VALLAURIX Research, Development and Innovation (RD&I) Centre in Singapore. This strategic five-year investment solidifies the site’s transition into a global hub for developing advanced, long-acting peptide formulations.

Read more at globenewswire.com

This article contains syndicated content. We have not reviewed, approved, or endorsed the content, and may receive compensation for placement of the content on this site. For more information please view the Barchart Disclosure Policy here.